Latest Stock Market News

​Specifically, we do not have a stock list ready, like a shopping list per se. We are still observing what has happened in the quarter which has gone by.

Dr. Reddy’s Laboratories fell 5.8% to Rs 1,128.90, while Zydus Lifesciences dropped 4.8%. Sun Pharma, India s largest drugmaker, declined by 3.2% to Rs 1,647.35, becoming the top loser on the BSE Sensex and one of the top five decliners on the Nifty 50.

Top brokerage firms highlight investment opportunities in stocks for 2025, projecting 20-30% returns. Motilal Oswal recommends UltraTech Cements and Glenmark Pharma, while JPMorgan favors Persistent Systems. Citi is optimistic about Shriram Finance and gives a neutral rating to United Spirits with notable potential gains. These recommendations entail stocks across various promising sectors.

Rate this item

(1 Vote)

These stocks 50-day SMA crossed below their 200-day SMAs on February 18.

The Indian market is expected to consolidate on Wednesday, influenced by muted global cues. The Nifty futures closed slightly negative, with significant options data suggesting a broader trading range between 22,500 to 23,500 zones. Various technical analysts have recommended stocks such as LTIMindTree, Cipla, NTPC, and Wipro for short-term trading with specified targets and stop losses.

Piramal Pharma shares will be in focus after the US FDA s GMP inspection at its Turbhe facility from February 11-17, 2025, resulting in a Form 483 with six observations. The company confirmed that these relate to procedural improvements, not data integrity. Additionally, Piramal reported a 13% YoY revenue growth in Q3FY25, with a strong target price outlook.

Rate this item

(1 Vote)

An uptrend signal occurs when the RSI value crosses above 50 from below.

ICICI Securities has raised its rating on GlaxoSmithKline Pharmaceuticals to Add from Hold with a new target price of Rs 2250. GSK Pharma s earnings are expected to see a CAGR of 15.3% over FY24-27. The company has an asset-light and cash-rich balance sheet, which could improve its return on equity and return on capital employed.

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.